Literature DB >> 1463680

A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents.

L G Gunnarsson1, L Bodin, B Söderfeldt, O Axelson.   

Abstract

Motor neurone disease (MND) was studied in relation to various determinants in a case-control study covering nine counties in southern Sweden. A questionnaire about occupational exposures, medical history, lifestyle factors etc was given to all cases in the age range 45-79 and to a random sample of 500 population controls in the same age range. The questionnaires were answered by 92 cases and 372 controls, a response rate of 85% and 75% respectively. Among men high Mantel-Haenszel odds ratios (MHORs) were obtained for electricity work (MHOR = 6.7, 95% confidence interval (95% CI) 1.0-32.1), welding (MHOR = 3.7, 95% CI 1.1-13.0), and impregnating agents (MHOR = 3.5, 95% CI 0.9-13.1). Heritability with regard to a neurodegenerative disease or thyroid disease seemed to predispose to a risk of developing MND (OR = 2.1, 95% CI 1.0-4.3). The highest OR was found for the combination of such heritability, exposure to solvents, and male sex (OR = 15.6, 95% CI 2.8-87.0), a combination that occurred for seven cases and three controls. Hereditary factors and external exposures had a different distribution among cases with the spinal type of MND than among cases with involvement of the pyramidal tract or bulbar paresis also.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463680      PMCID: PMC1039327          DOI: 10.1136/oem.49.11.791

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  26 in total

1.  Risk factors in motor neuron disease: a case-control study.

Authors:  A Chió; P Meineri; A Tribolo; D Schiffer
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282

Review 2.  TRH and TRH receptors in the spinal cord.

Authors:  A Winokur; S Manaker; M S Kreider
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Results of a questionnaire in 100 ALS patients and 100 control cases.

Authors:  W A den Hartog Jager; P W Hanlo; B J Ansink; M B Vermeulen
Journal:  Clin Neurol Neurosurg       Date:  1987       Impact factor: 1.876

4.  Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

5.  Antecedent events in motor neuron disease.

Authors:  M Gawel; Z Zaiwalla; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

6.  Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths.

Authors:  J F Kurtzke; G W Beebe
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

7.  Multiple sclerosis and amyotrophic lateral sclerosis in Mississippi.

Authors:  A E Breland; R D Currier
Journal:  Neurology       Date:  1967-10       Impact factor: 9.910

8.  Amyotrophic lateral sclerosis. Clinical features and prognosis.

Authors:  A D Rosen
Journal:  Arch Neurol       Date:  1978-10

9.  Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study.

Authors:  K Murros; R Fogelholm
Journal:  Acta Neurol Scand       Date:  1983-01       Impact factor: 3.209

10.  ALS and pet exposure.

Authors:  S Tarras; N Schenkman; R Boesch; M Mulvihill; J T Caroscio
Journal:  Neurology       Date:  1985-05       Impact factor: 9.910

View more
  32 in total

1.  Evaluation of occupational exposure to magnetic fields and motor neuron disease mortality in a population-based cohort.

Authors:  Lauren E Parlett; Joseph D Bowman; Edwin van Wijngaarden
Journal:  J Occup Environ Med       Date:  2011-12       Impact factor: 2.162

Review 2.  Role of manganese in neurodegenerative diseases.

Authors:  Aaron B Bowman; Gunnar F Kwakye; Elena Herrero Hernández; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2011-10-01       Impact factor: 3.849

Review 3.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

4.  Association of fractures with the incidence of amyotrophic lateral sclerosis.

Authors:  Tracy L Peters; Caroline E Weibull; Fang Fang; Dale P Sandler; Paul C Lambert; Weimin Ye; Freya Kamel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-20       Impact factor: 4.092

Review 5.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

6.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964-1998.

Authors:  Vittorio Govoni; Enrico Granieri; Elisa Fallica; Ilaria Casetta
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

7.  Occupational exposures and the risk of amyotrophic lateral sclerosis.

Authors:  Tracy L Peters; Freya Kamel; Cecilia Lundholm; Maria Feychting; Caroline E Weibull; Dale P Sandler; Pernilla Wiebert; Pär Sparén; Weimin Ye; Fang Fang
Journal:  Occup Environ Med       Date:  2016-07-14       Impact factor: 4.402

8.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

9.  Workplace exposures and the risk of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Patricia Quinlan; Weimin Ye; Marie K Barber; David M Umbach; Dale P Sandler; Freya Kamel
Journal:  Environ Health Perspect       Date:  2009-05-11       Impact factor: 9.031

10.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.